NCDHHS 2022 Monkeypox Outbreak Response Plan
NCDHHS 2022 Monkeypox Outbreak Response Plan
NCDHHS 2022 Monkeypox Outbreak Response Plan
Outbreak
North Carolina’s Response Plan
NCDHHS and providers, local health departments and community groups are working to protect people
from monkeypox and slow spread of this disease. To do this, the department and its partners are sharing
information about monkeypox and what behaviors make people at a higher risk of getting monkey pox.
People with symptoms are encouraged to get tested, isolate and talk to their health care provider about
treatment. In addition, health departments identify contacts of infected people and offer them vaccines.
On June 28, the federal government made more vaccines available to protect people with more risk
for catching monkeypox. This document details North Carolina’s plan to distribute vaccine and slow
the spread of disease.
WHAT IS MONKEYPOX?
Monkeypox is a rare disease caused by an orthopox virus. Prior to the 2022 outbreak, nearly all
monkeypox cases in people outside of Africa were linked to international travel to countries where
the disease commonly occurs.
Early symptoms can include fever, exhaustion and headache, and sometimes a sore throat and cough.
A rash that can look like pimples or blisters appears shortly after. This happens over two to three
weeks. More information is available online.
1
WHO IS AT RISK?
Anyone can get monkeypox. Many of the cases in this outbreak so far have been in men who have sex
with men and transgender individuals. Sex can have a lot of close skin-to-skin contact, making it a riskier
activity for spreading the virus. People who have more than one sexual partner in an area or venue where
monkeypox is spreading are at higher risk of getting infected. For an update on the spread of the virus,
visit the CDC map of monkeypox spread. Some cases have been tied to venue and events like sex parties
and saunas where intimate, often anonymous sexual contact with multiple partners may occur.
TESTING
Testing is available through a health care provider or local health department. The State Laboratory
of Public Health tests these samples. Some commercial labs and academic medical centers can also
test for monkeypox including LabCorp and the Mayo Clinic. There is no shortage of testing supplies,
and people with symptoms of monkeypox should go to their health care provider or a local health
department to get tested.
TREATMENT
While no medicine is specifically developed for monkeypox infections, treatment is available.
Medications developed for similar viruses may be used to treat severe cases. Discuss treatment
options with your health care provider.
VACCINE
JYNNEOS is a vaccine that prevents or reduces the severity of monkeypox. It must be given within 14 days
after exposure. It can also be given before exposure to those at high risk. People need to have two
doses of the vaccine. A second vaccine that is approved for prevention of smallpox, ACAM2000, also
protects against monkeypox. It has higher risks than JYNNEOS. It is not recommended for people
who have some skin diseases, a compromised immune system, or a range of other conditions.
Criteria for receiving vaccine may change. As of this update, vaccine will go first to known contacts of
confirmed cases to prevent disease (post-exposure prophylaxis). Limited vaccines are available for gay or
bisexual men or transgender individuals who had multiple sex partners or anonymous sex in the last 14 days.
PHASE 1
People who had close contact with cases in North Carolina are being offered JYNNEOS vaccine.
On July 6, vaccine began arriving in the state. Initially seven health departments received vaccine:
Buncombe, Durham, Forsyth, Mecklenburg, New Hanover, Pitt, and Wake. Vaccine is transferred as
needed to other health departments, sites or tribal populations.
Contact tracing is a critical part of Phase 1 response, as vaccine will go first to known contacts of
confirmed cases. Vaccine is also administered to people who meet the above criteria and are at
higher risk. Vaccinations are recorded in the North Carolina Immunization Registry.
2
PHASE 2A
A second allocation of JYNNEOS vaccines was made
available in mid-July and will include enough vaccines for
about 960 people statewide. Vaccine will be prioritized for
people who received a first dose in Phase 1 and to those
higher at risk according to the above criteria. In addition,
certain laboratory, healthcare, and public health response
personnel will be eligible for JYNNEOS vaccines.
PROVIDERS
The first provider communication on monkeypox was sent on May 20 alerting medical care providers
to the outbreak. The communication detailed the symptoms, the rash, and the procedure to collect
samples for testing. Provider communications are updated and sent as conditions change.
3
GENERAL PUBLIC
NCDHHS created a web page outlining the details of monkeypox, including a fact sheet and a
frequently asked questions document. The page is a landing spot for social media posts and press
releases that increase knowledge of the virus. A communications toolkit is available on the website.
A case count will be posted on the site, and a count of vaccines will follow. NCDHHS will continue to
update web resources and issue press releases as the situation changes.
Keep the rash covered and avoid sex or being intimate with anyone until you have been seen by a
health care provider. Monkeypox is usually a self-limited disease with the symptoms lasting from
two to four weeks, though severe cases can occur. Standard household cleaners and detergents are
effective for cleaning environmental surfaces and linens.
More Information
More information can be found on the Division of Public Health
Monkeypox Website and the CDC website:
• Signs and Symptoms
• How it Spreads
• Monkeypox Facts for People Who are Sexually Active
Monkeypox Photo Credits: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division
of High-Consequence Pathogens and Pathology (DHCPP), www.cdc.gov/poxvirus/monkeypox/clinicians/clinical-recognition.html • NHS England High
Consequence Infectious Diseases Network, www.gov.uk/government/news/ukhsa-latest-findings-into-monkeypox-outbreak, The National Archives,
contains public sector information licensed under the Open Government Licence v3.0.